| Dfw Home Health | |
| 8440 Walnut Hill Lane, Suite 840, Dallas, Texas 75231 | |
| (214) 891-8700 | |
| Name | Dfw Home Health |
|---|---|
| Location | 8440 Walnut Hill Lane, Suite 840, Dallas, Texas |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 458444 |
| Ownership Type | Voluntary Non Profit - Religious Affiliation |
| Service Area Zip Codes | 75001, 75002, 75006, 75007, 75009, 75010, 75011, 75013, 75019, 75020, 75022, 75023, 75024, 75025, 75028, 75032, 75033, 75034, 75035, 75038, 75039, 75040, 75041, 75042, 75043, 75044, 75048, 75050, 75051, 75052, 75054, 75056, 75057, 75058, 75060, 75061, 75062, 75063, 75065, 75067, 75068, 75069, 75070, 75071, 75074, 75075, 75076, 75077, 75078, 75080, 75081, 75082, 75087, 75088, 75089, 75092, 75093, 75094, 75098, 75104, 75115, 75116, 75119, 75125, 75126, 75134, 75137, 75141, 75142, 75146, 75149, 75150, 75152, 75154, 75159, 75165, 75166, 75167, 75172, 75173, 75180, 75181, 75182, 75189, 75201, 75202, 75203, 75204, 75205, 75206, 75208, 75209, 75210, 75211, 75212, 75214, 75215, 75216, 75217, 75218, 75219, 75220, 75223, 75224, 75225, 75227, 75228, 75229, 75230, 75231, 75232, 75233, 75234, 75235, 75236, 75237, 75238, 75240, 75241, 75242, 75243, 75244, 75246, 75247, 75248, 75249, 75251, 75252, 75253, 75254, 75287, 75407, 75409, 75424, 75442, 75452, 75454, 75489, 75495, 76006, 76010, 76011, 76021, 76031, 76034, 76036, 76040, 76063, 76084, 76112, 76201, 76205, 76207, 76208, 76209, 76210, 76226, 76227, 76233, 76234, 76247, 76249, 76258, 76259, 76266, 76272 |
| NPI Number | 1003969130 |
| Organization Name | BETHESDA HOME HEALTH CARE, PLLC |
| Address | 8204 Elmbrook Dr, Suite 135, Dallas, TX 75247 |
| Phone Number | 214-879-0803 |
News Archive
Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese
Surgical removal of a tissue sample is now the standard for diagnosing cancer. Such procedures, known as biopsies, are accurate but only offer a snapshot of the tumor at a single moment in time.
The NDSU Research Foundation and OncoThira have entered into a license agreement involving technology developed at North Dakota State University.
On August 9, 2010 Massachusetts passed Chapter 283 of the Acts of 2010, adding Safeguards to the Prescription Monitoring Program and furthering Substance Abuse Education and Prevention. Section 11 of the act requires all pharmacies in Massachusetts that dispense schedule II, III, IV, or V prescription drugs to make available lock boxes for sale at each location.
› Verified 8 days ago
| NPI Number | 1043576911 |
| Organization Name | LHCG XXXIII, LLC |
| Doing Business As | DFW HOME HEALTH |
| Address | 13140 Coit Rd Ste 450, Dallas, TX 75240 |
| Phone Number | 214-891-8700 |
News Archive
Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese
Surgical removal of a tissue sample is now the standard for diagnosing cancer. Such procedures, known as biopsies, are accurate but only offer a snapshot of the tumor at a single moment in time.
The NDSU Research Foundation and OncoThira have entered into a license agreement involving technology developed at North Dakota State University.
On August 9, 2010 Massachusetts passed Chapter 283 of the Acts of 2010, adding Safeguards to the Prescription Monitoring Program and furthering Substance Abuse Education and Prevention. Section 11 of the act requires all pharmacies in Massachusetts that dispense schedule II, III, IV, or V prescription drugs to make available lock boxes for sale at each location.
› Verified 8 days ago
| NPI Number | 1174556302 |
| Organization Name | ABIDING HOME HEALTH OF DALLAS, LLC |
| Address | 8204 Elmbrook Dr, #135, Dallas, TX 75247 |
| Phone Number | 214-879-0803 |
News Archive
Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese
Surgical removal of a tissue sample is now the standard for diagnosing cancer. Such procedures, known as biopsies, are accurate but only offer a snapshot of the tumor at a single moment in time.
The NDSU Research Foundation and OncoThira have entered into a license agreement involving technology developed at North Dakota State University.
On August 9, 2010 Massachusetts passed Chapter 283 of the Acts of 2010, adding Safeguards to the Prescription Monitoring Program and furthering Substance Abuse Education and Prevention. Section 11 of the act requires all pharmacies in Massachusetts that dispense schedule II, III, IV, or V prescription drugs to make available lock boxes for sale at each location.
› Verified 8 days ago
| NPI Number | 1215132329 |
| Organization Name | HARMAN HEALTHCARE, LLC |
| Doing Business As | DFW HOME HEALTH |
| Address | 8204 Elmbrook Dr, Suite 190, Dallas, TX 75247 |
| Phone Number | 214-879-0803 |
News Archive
Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese
Surgical removal of a tissue sample is now the standard for diagnosing cancer. Such procedures, known as biopsies, are accurate but only offer a snapshot of the tumor at a single moment in time.
The NDSU Research Foundation and OncoThira have entered into a license agreement involving technology developed at North Dakota State University.
On August 9, 2010 Massachusetts passed Chapter 283 of the Acts of 2010, adding Safeguards to the Prescription Monitoring Program and furthering Substance Abuse Education and Prevention. Section 11 of the act requires all pharmacies in Massachusetts that dispense schedule II, III, IV, or V prescription drugs to make available lock boxes for sale at each location.
› Verified 8 days ago
| NPI Number | 1982964441 |
| Organization Name | AD HEALTHCARE AGENCY INC |
| Address | 8204 Elmbrook Dr, Ste 305a, Dallas, TX 75247 |
| Phone Number | 214-934-8993 |
News Archive
Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese
Surgical removal of a tissue sample is now the standard for diagnosing cancer. Such procedures, known as biopsies, are accurate but only offer a snapshot of the tumor at a single moment in time.
The NDSU Research Foundation and OncoThira have entered into a license agreement involving technology developed at North Dakota State University.
On August 9, 2010 Massachusetts passed Chapter 283 of the Acts of 2010, adding Safeguards to the Prescription Monitoring Program and furthering Substance Abuse Education and Prevention. Section 11 of the act requires all pharmacies in Massachusetts that dispense schedule II, III, IV, or V prescription drugs to make available lock boxes for sale at each location.
› Verified 8 days ago
| Quality Rating: |
News Archive
Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese
Surgical removal of a tissue sample is now the standard for diagnosing cancer. Such procedures, known as biopsies, are accurate but only offer a snapshot of the tumor at a single moment in time.
The NDSU Research Foundation and OncoThira have entered into a license agreement involving technology developed at North Dakota State University.
On August 9, 2010 Massachusetts passed Chapter 283 of the Acts of 2010, adding Safeguards to the Prescription Monitoring Program and furthering Substance Abuse Education and Prevention. Section 11 of the act requires all pharmacies in Massachusetts that dispense schedule II, III, IV, or V prescription drugs to make available lock boxes for sale at each location.
› Verified 8 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 99.6 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.9 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 99.9 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 87.9 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 86.8 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 99.1 | 96.4 |
News Archive
Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese
Surgical removal of a tissue sample is now the standard for diagnosing cancer. Such procedures, known as biopsies, are accurate but only offer a snapshot of the tumor at a single moment in time.
The NDSU Research Foundation and OncoThira have entered into a license agreement involving technology developed at North Dakota State University.
On August 9, 2010 Massachusetts passed Chapter 283 of the Acts of 2010, adding Safeguards to the Prescription Monitoring Program and furthering Substance Abuse Education and Prevention. Section 11 of the act requires all pharmacies in Massachusetts that dispense schedule II, III, IV, or V prescription drugs to make available lock boxes for sale at each location.
› Verified 8 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 82.5 | 79.6 |
| How often patients got better at getting in and out of bed | 82.6 | 81.1 |
| How often patients got better at bathing | 87.8 | 82.3 |
| How often patients’ breathing improved | 86.1 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 93.9 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 79.4 | 75 |
| How often home health patients had to be admitted to the hospital | 12.6 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 11.2 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 99.2 | 94 |
News Archive
Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese
Surgical removal of a tissue sample is now the standard for diagnosing cancer. Such procedures, known as biopsies, are accurate but only offer a snapshot of the tumor at a single moment in time.
The NDSU Research Foundation and OncoThira have entered into a license agreement involving technology developed at North Dakota State University.
On August 9, 2010 Massachusetts passed Chapter 283 of the Acts of 2010, adding Safeguards to the Prescription Monitoring Program and furthering Substance Abuse Education and Prevention. Section 11 of the act requires all pharmacies in Massachusetts that dispense schedule II, III, IV, or V prescription drugs to make available lock boxes for sale at each location.
› Verified 8 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese
Surgical removal of a tissue sample is now the standard for diagnosing cancer. Such procedures, known as biopsies, are accurate but only offer a snapshot of the tumor at a single moment in time.
The NDSU Research Foundation and OncoThira have entered into a license agreement involving technology developed at North Dakota State University.
On August 9, 2010 Massachusetts passed Chapter 283 of the Acts of 2010, adding Safeguards to the Prescription Monitoring Program and furthering Substance Abuse Education and Prevention. Section 11 of the act requires all pharmacies in Massachusetts that dispense schedule II, III, IV, or V prescription drugs to make available lock boxes for sale at each location.
› Verified 8 days ago
The patient survey data of Dfw Home Health is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 88 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 87 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 85 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 82 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 76 | 78 |
News Archive
Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese
Surgical removal of a tissue sample is now the standard for diagnosing cancer. Such procedures, known as biopsies, are accurate but only offer a snapshot of the tumor at a single moment in time.
The NDSU Research Foundation and OncoThira have entered into a license agreement involving technology developed at North Dakota State University.
On August 9, 2010 Massachusetts passed Chapter 283 of the Acts of 2010, adding Safeguards to the Prescription Monitoring Program and furthering Substance Abuse Education and Prevention. Section 11 of the act requires all pharmacies in Massachusetts that dispense schedule II, III, IV, or V prescription drugs to make available lock boxes for sale at each location.
› Verified 8 days ago
New Era Home Healthcare Services Inc Location: 9221 Lbj Freeway Suite 107, Dallas, Texas 75243 Ratings: NA Phone: (972) 235-0009 | |
Home Care Providers Of Texas Location: 5339 Alpha Road Suite 200, Dallas, Texas 75240 Ratings: Phone: (214) 435-2249 | |
Dallas Horizon Home Health Agency Llc Location: 2775 Villa Creek Dr. Suite 123, Dallas, Texas 75234 Ratings: NA Phone: (972) 241-8633 | |
Provista Healthcare Location: 4849 Greenville Ave Ste 1124, Dallas, Texas 75206 Ratings: Phone: (214) 965-0431 | |
Alliance A Plus Home Health Care Inc Location: 7125 Marvin D Love Freeway Suite 320, Dallas, Texas 75237 Ratings: Phone: (214) 596-9357 | |